Advertisement

Disparities in Breast Cancer Outcomes and How to Resolve Them

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Hematology/Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sung H.
        • Ferlay J.
        • Siegel R.L.
        • et al.
        Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2021; 71: 209-249
        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • et al.
        Cancer Statistics, 2021.
        CA Cancer J Clin. 2021; 71: 7-33
        • Ward E.M.
        • DeSantis C.E.
        • Lin C.C.
        • et al.
        Cancer statistics: Breast cancer in situ.
        CA Cancer J Clin. 2015; 65: 481-495
        • Crew K.D.
        • Albain K.S.
        • Hershman D.L.
        • et al.
        How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?.
        NPJ Breast Cancer. 2017; 3: 20
        • Stedman M.R.
        • Feuer E.J.
        • Mariotto A.B.
        Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
        J Natl Cancer Inst Monogr. 2014; 2014: 244-254
        • Plevritis S.K.
        • Munoz D.
        • Kurian A.W.
        • et al.
        Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
        Jama. 2018; 319: 154-164
        • Brawley O.W.
        Health disparities in breast cancer.
        Obstet Gynecol Clin North Am. 2013; 40: 513-523
        • Friedman D.J.
        • Cohen B.B.
        • Averbach A.R.
        • et al.
        Race/ethnicity and OMB Directive 15: implications for state public health practice.
        Am J Public Health. 2000; 90: 1714-1719
        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • et al.
        Cancer statistics, 2022.
        CA Cancer J Clin. 2022; 72: 7-33
        • Elhaik E.
        • Tatarinova T.
        • Chebotarev D.
        • et al.
        Geographic population structure analysis of worldwide human populations infers their biogeographical origins.
        Nat Commun. 2014; 5: 3513
        • Koromina M.
        • Pandi M.T.
        • van der Spek P.J.
        • et al.
        The ethnogeographic variability of genetic factors underlying G6PD deficiency.
        Pharmacol Res. 2021; 173: 105904
        • Nyante S.J.
        • Abraham L.
        • Aiello Bowles E.J.
        • et al.
        Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.
        Cancer Epidemiol Biomarkers Prev. 2022; 31: 1324-1333
        • Lawson M.B.
        • Bissell M.C.S.
        • Miglioretti D.L.
        • et al.
        Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
        JAMA Oncol. 2022; https://doi.org/10.1001/jamaoncol.2022.1990
        • Howlader N.N.A.
        • Krapcho M.
        • Miller D.
        • et al.
        SEER Cancer Statistics Review, 1975-2017. 2020.
        (Available at:)
        • DeSantis C.E.
        • Miller K.D.
        • Goding Sauer A.
        • et al.
        Cancer statistics for African Americans, 2019.
        CA Cancer J Clin. 2019; 69: 211-233
        • Kong X.
        • Liu Z.
        • Cheng R.
        • et al.
        Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
        JAMA Netw Open. 2020; 3: e2020303
        • DeSantis C.E.
        • Ma J.
        • Gaudet M.M.
        • et al.
        Breast cancer statistics, 2019.
        CA Cancer J Clin. 2019; 69: 438-451
        • Howard F.M.
        • Olopade O.I.
        Epidemiology of Triple-Negative Breast Cancer: A Review.
        Cancer J. 2021; 27: 8-16
        • Sung H.
        • DeSantis C.
        • Jemal A.
        Subtype-Specific Breast Cancer Incidence Rates in Black versus White Men in the United States.
        JNCI Cancer Spectr. 2020; 4: pkz091
        • Islami F.
        • Goding Sauer A.
        • Miller K.D.
        • et al.
        Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.
        CA Cancer J Clin. 2018; 68: 31-54
        • Calle E.E.
        • Rodriguez C.
        • Walker-Thurmond K.
        • et al.
        Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
        N Engl J Med. 2003; 348: 1625-1638
        • Islami F.
        • Siegel R.L.
        • Jemal A.
        The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.
        Nat Rev Clin Oncol. 2020; 17: 631-649
        • Ogden C.L.
        • Fryar C.D.
        • Martin C.B.
        • et al.
        Trends in Obesity Prevalence by Race and Hispanic Origin-1999-2000 to 2017-2018.
        Jama. 2020; 324: 1208-1210
        • Ambrosone C.B.
        • Zirpoli G.
        • Ruszczyk M.
        • et al.
        Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.
        Cancer Causes Control. 2014; 25: 259-265
        • Lambertini M.
        • Santoro L.
        • Del Mastro L.
        • et al.
        Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.
        Cancer Treat Rev. 2016; 49: 65-76
        • Ravdin P.M.
        • Cronin K.A.
        • Howlader N.
        • et al.
        The decrease in breast-cancer incidence in 2003 in the United States.
        N Engl J Med. 2007; 356: 1670-1674
        • Pal T.
        • Bonner D.
        • Cragun D.
        • et al.
        A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
        Cancer. 2015; 121: 4173-4180
        • Offit K.
        • Gilewski T.
        • McGuire P.
        • et al.
        Germline BRCA1 185delAG mutations in Jewish women with breast cancer.
        Lancet. 1996; 347: 1643-1645
        • Cragun D.
        • Weidner A.
        • Lewis C.
        • et al.
        Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
        Cancer. 2017; 123: 2497-2505
        • Friebel T.M.
        • Andrulis I.L.
        • Balmaña J.
        • et al.
        BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.
        Hum Mutat. 2019; 40: 1781-1796
        • Ndiaye R.
        • Diop J.P.D.
        • Bourdon-Huguenin V.
        • et al.
        Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal.
        NPJ Genom Med. 2020; 5: 8
        • Nanda R.
        • Schumm L.P.
        • Cummings S.
        • et al.
        Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
        Jama. 2005; 294: 1925-1933
        • Sung H.
        • DeSantis C.E.
        • Fedewa S.A.
        • et al.
        Breast cancer subtypes among Eastern-African-born black women and other black women in the United States.
        Cancer. 2019; 125: 3401-3411
        • Pinheiro P.S.
        • Medina H.
        • Callahan K.E.
        • et al.
        Cancer mortality among US blacks: Variability between African Americans, Afro-Caribbeans, and Africans.
        Cancer Epidemiol. 2020; 66: 101709
        • Lara O.D.
        • Wang Y.
        • Asare A.
        • et al.
        Pan-cancer clinical and molecular analysis of racial disparities.
        Cancer. 2020; 126: 800-807
        • Jiang Y.
        • Cui L.
        • Chen W.D.
        • et al.
        The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data.
        PLoS One. 2012; 7: e36780
        • Mehrotra J.
        • Ganpat M.M.
        • Kanaan Y.
        • et al.
        Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.
        Clin Cancer Res. 2004; 10: 2052-2057
        • del Carmen M.G.
        • Halpern E.F.
        • Kopans D.B.
        • et al.
        Mammographic breast density and race.
        AJR Am J Roentgenol. 2007; 188: 1147-1150
        • Goding Sauer A.
        • Siegel R.L.
        • Jemal A.
        • et al.
        Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity.
        Cancer Epidemiol Biomarkers Prev. 2019; 28: 629-642
        • Betancourt J.R.
        • Tan-McGrory A.
        • Flores E.
        • et al.
        Racial and Ethnic Disparities in Radiology: A Call to Action.
        J Am Coll Radiol. 2019; 16: 547-553
        • Rauscher G.H.
        • Murphy A.M.
        • Orsi J.M.
        • et al.
        Beyond the mammography quality standards act: measuring the quality of breast cancer screening programs.
        AJR Am J Roentgenol. 2014; 202: 145-151
        • Ansell D.
        • Grabler P.
        • Whitman S.
        • et al.
        A community effort to reduce the black/white breast cancer mortality disparity in Chicago.
        Cancer Causes Control. 2009; 20: 1681-1688
        • Griggs J.J.
        • Sorbero M.E.
        • Lyman G.H.
        Undertreatment of obese women receiving breast cancer chemotherapy.
        Arch Intern Med. 2005; 165: 1267-1273
        • Cohen S.S.
        • Palmieri R.T.
        • Nyante S.J.
        • et al.
        Obesity and screening for breast, cervical, and colorectal cancer in women: a review.
        Cancer. 2008; 112: 1892-1904
        • Elmore J.G.
        • Carney P.A.
        • Abraham L.A.
        • et al.
        The association between obesity and screening mammography accuracy.
        Arch Intern Med. 2004; 164: 1140-1147
        • Lund M.J.
        • Brawley O.P.
        • Ward K.C.
        • et al.
        Parity and disparity in first course treatment of invasive breast cancer.
        Breast Cancer Res Treat. 2008; 109: 545-557
        • Silber J.H.
        • Rosenbaum P.R.
        • Clark A.S.
        • et al.
        Characteristics associated with differences in survival among black and white women with breast cancer.
        Jama. 2013; 310: 389-397
        • Freedman R.A.
        • He Y.
        • Winer E.P.
        • et al.
        Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?.
        Health Serv Res. 2013; 48: 1669-1683
        • Griggs J.J.
        • Sorbero M.E.
        • Stark A.T.
        • et al.
        Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy.
        Breast Cancer Res Treat. 2003; 81: 21-31
        • Obeng-Gyasi S.
        • Asad S.
        • Fisher J.L.
        • et al.
        Socioeconomic and Surgical Disparities are Associated with Rapid Relapse in Patients with Triple-Negative Breast Cancer.
        Ann Surg Oncol. 2021; 28: 6500-6509
        • Breslin T.M.
        • Morris A.M.
        • Gu N.
        • et al.
        Hospital factors and racial disparities in mortality after surgery for breast and colon cancer.
        J Clin Oncol. 2009; 27: 3945-3950
        • Bickell N.A.
        • Wang J.J.
        • Oluwole S.
        • et al.
        Missed opportunities: racial disparities in adjuvant breast cancer treatment.
        J Clin Oncol. 2006; 24: 1357-1362
        • Partridge A.H.
        • Wang P.S.
        • Winer E.P.
        • et al.
        Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
        J Clin Oncol. 2003; 21: 602-606
        • Wu X.C.
        • Lund M.J.
        • Kimmick G.G.
        • et al.
        Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
        J Clin Oncol. 2012; 30: 142-150
        • Huiart L.
        • Ferdynus C.
        • Giorgi R.
        A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians.
        Breast Cancer Res Treat. 2013; 138: 325-328
        • Lannin D.R.
        • Mathews H.F.
        • Mitchell J.
        • et al.
        Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer.
        Jama. 1998; 279: 1801-1807
        • Warner E.T.
        • Tamimi R.M.
        • Hughes M.E.
        • et al.
        Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
        J Clin Oncol. 2015; 33: 2254-2261
        • Griggs J.J.
        • Culakova E.
        • Sorbero M.E.
        • et al.
        Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
        J Clin Oncol. 2007; 25: 2522-2527
        • Griggs J.J.
        • Culakova E.
        • Sorbero M.E.
        • et al.
        Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.
        J Clin Oncol. 2007; 25: 277-284
        • Li C.I.
        • Beaber E.F.
        • Tang M.T.
        • et al.
        Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.
        Breast Cancer Res Treat. 2013; 137: 579-587
        • Siegel R.
        • Ward E.
        • Brawley O.
        • et al.
        Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.
        CA Cancer J Clin. 2011; 61: 212-236
        • Zhao J.
        • Mao Z.
        • Fedewa S.A.
        • et al.
        The Affordable Care Act and access to care across the cancer control continuum: A review at 10 years.
        CA Cancer J Clin. 2020; 70: 165-181
        • Le Blanc J.M.
        • Heller D.R.
        • Friedrich A.
        • et al.
        Association of Medicaid Expansion Under the Affordable Care Act With Breast Cancer Stage at Diagnosis.
        JAMA Surg. 2020; 155: 1-7
        • Fedewa S.A.
        • Yabroff K.R.
        • Smith R.A.
        • et al.
        Changes in Breast and Colorectal Cancer Screening After Medicaid Expansion Under the Affordable Care Act.
        Am J Prev Med. 2019; 57: 3-12
        • Albain K.S.
        • Unger J.M.
        • Crowley J.J.
        • et al.
        Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
        J Natl Cancer Inst. 2009; 101: 984-992
        • Dess R.T.
        • Hartman H.E.
        • Mahal B.A.
        • et al.
        Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
        JAMA Oncol. 2019; 5: 975-983
        • Lehrberg A.
        • Davis M.B.
        • Baidoun F.
        • et al.
        Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.
        Breast J. 2021; 27: 573-580
        • Roseland M.E.
        • Schwartz K.
        • Ruterbusch J.J.
        • et al.
        Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
        Breast Cancer Res Treat. 2017; 165: 163-168
        • Dignam J.J.
        Re: Racial disparities in cancer survival among randomized clinical trials of the Southwest Oncology Group.
        J Natl Cancer Inst. 2010; 102 ([author reply: 280–2]): 279-280
        • Hershman D.L.
        • Unger J.M.
        • Barlow W.E.
        • et al.
        Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.
        J Clin Oncol. 2009; 27: 2157-2162
        • Omilian A.R.
        • Wei L.
        • Hong C.C.
        • et al.
        Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
        Breast Cancer Res Treat. 2020; 182: 503-509
        • Siegel R.L.
        • Jemal A.
        • Wender R.C.
        • et al.
        An assessment of progress in cancer control.
        CA Cancer J Clin. 2018; 68: 329-339
        • Gabram S.G.
        • Lund M.J.
        • Gardner J.
        • et al.
        Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population.
        Cancer. 2008; 113: 602-607
        • Natale-Pereira A.
        • Enard K.R.
        • Nevarez L.
        • et al.
        The role of patient navigators in eliminating health disparities.
        Cancer. 2011; 117: 3543-3552
        • Starbird L.E.
        • DiMaina C.
        • Sun C.A.
        • et al.
        A Systematic Review of Interventions to Minimize Transportation Barriers Among People with Chronic Diseases.
        J Community Health. 2019; 44: 400-411
        • Polite B.N.
        • Gluck A.R.
        • Brawley O.W.
        Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.
        Jama. 2019; 321: 1663-1664
        • Ma J.
        • Jemal A.
        • Fedewa S.A.
        • et al.
        The American Cancer Society 2035 challenge goal on cancer mortality reduction.
        CA Cancer J Clin. 2019; 69: 351-362